Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer.
about
Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer: a Systematic Review and Meta-Analysis.Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis.S-1 in the treatment of pancreatic cancer.Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial.S-1-based regimens and the risk of oral and gastrointestinal mucosal injury: a meta-analysis with comparison to other fluoropyrimidines.Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer.Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells.Knockdown of glucose-regulated protein 78 enhances poly(ADP-ribose) polymerase cleavage in human pancreatic cancer cells exposed to endoplasmic reticulum stressSystematic Review and Case Series Report of Acinar Cell Carcinoma of the Pancreas.Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapy.Efficacy of different chemotherapy regimens in treatment of advanced or metastatic pancreatic cancer: A network meta-analysis.
P2860
Q26786174-31D20833-0502-4DBB-9679-0C091A1BD63AQ33421322-7482B9D1-E73F-4A41-A986-4559641173CEQ33427177-303376D7-DC4E-4F1F-85B0-831778B61677Q33440500-DEC82383-A5EF-45A6-9F5A-F49A8776E682Q33442676-D93E3932-CB67-4D8A-AADB-D821C1615804Q34467156-0B3F2F62-043B-4DA1-94F2-D74FAC90F1DAQ37295836-99CBDD86-06F3-4AB6-97FE-3C75C980CD3DQ38619215-A338DEE2-7C42-46DA-9A5D-0FAE74D210B3Q38673039-2A38E871-07E6-4D79-B131-526B5F651D4DQ38779523-81677F19-68FB-43B4-A3D2-37BF2AFDDFDDQ38845658-57C2CB74-FC3D-4710-A980-BAAC265E4BF4Q38946261-9E57B4AD-AA35-4CF7-9FC8-0B2F6B97D41CQ39008039-32487D57-B31E-431C-9BA8-8E218575CC1FQ39150005-15497A65-4F65-4D52-9A32-F438FC5E43A2Q48323904-9F078093-8D2A-4116-B486-45EB0EA43D94
P2860
Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Randomized controlled study of ...... nresectable pancreatic cancer.
@ast
Randomized controlled study of ...... nresectable pancreatic cancer.
@en
type
label
Randomized controlled study of ...... nresectable pancreatic cancer.
@ast
Randomized controlled study of ...... nresectable pancreatic cancer.
@en
prefLabel
Randomized controlled study of ...... nresectable pancreatic cancer.
@ast
Randomized controlled study of ...... nresectable pancreatic cancer.
@en
P2093
P2860
P1476
Randomized controlled study of ...... nresectable pancreatic cancer.
@en
P2093
Akihiko Nakagawa
Fumiaki Ozawa
Katsunobu Tawada
Kazuyoshi Nakamura
Kenji Shimura
Kentaro Sudo
Motohisa Tada
Nobuto Hirata
Osamu Yokosuka
Rintaro Mikata
P2860
P2888
P304
P356
10.1007/S00280-013-2368-6
P577
2013-12-10T00:00:00Z
P6179
1030418474